TABLE 1.
Participant demographics.
| MetS | Control | t | p | |
|---|---|---|---|---|
| Male/Female (n) | 6/7 | 6/7 | — | — |
| Age (years) | 28 ± 12 | 30 ± 13 | 0.401 | 0.34 |
| MVC (kg) | 45.6 ± 14.0 | 37.3 ± 11.9 | 1.646 | 0.05 |
| Height (cm) | 172.9 ± 10.6 | 168.3 ± 10.8 | 1.107 | 0.14 |
| Weight (kg) | 106.7 ± 39.2 | 74.7 ± 21.4 | 2.588 | <0.01* |
| BMI (kg/m2) | 35.0 ± 10.1 | 26.1 ± 6.6 | 2.653 | <0.01* |
| WC (cm) | 109.4 ± 24.3 | 86.3 ± 14.8 | 2.933 | <0.01* |
| FBG (mg/dL) | 98 ± 13 | 88 ± 6 | 2.468 | 0.01* |
| HbA1C (%) | 5.29 ± 0.66 | 4.97 ± 0.27 | 1.640 | 0.05 |
| OGT (mg/dL) | 107 ± 27 | 107 ± 14 | 0.054 | 0.47 |
| RSBP (mmHg) | 118 ± 12 | 115 ± 10 | 0.841 | 0.20 |
| RDBP (mmHg) | 83 ± 12 | 75 ± 9 | 1.974 | 0.03* |
| RHR (bpm) | 70 ± 15 | 63 ± 10 | 1.391 | 0.08 |
| HDL-C (mg/dL) | 36 ± 11 | 50 ± 11 | 3.212 | <0.01* |
| LDL-C (mg/dL) | 103 ± 15 | 88 ± 22 | 1.595 | 0.06 |
| TRG (mg/dL) | 211 ± 219 | 113 ± 89 | 1.501 | 0.07 |
| TC (mg/dL) | 161 ± 48 | 160 ± 29 | 0.099 | 0.46 |
| Total Body Fat (%) | 34.6 ± 6.8 | 28.5 ± 6.7 | 2.299 | 0.01* |
| Fat Mass (kg) | 39.6 ± 18.6 | 20.2 ± 9.6 | 3.340 | <0.01* |
| Fat-Free Mass (kg) | 70.2 ± 20.2 | 51.1 ± 13.2 | 2.856 | <0.01* |
| MetSindex | 0.74 ± 1.06 | −0.52 ± 0.68 | 3.620 | <0.01* |
MetS, metabolic syndrome group; t, absolute value of the t-statistic; p, p-value; BMI, body mass index; WC, waist circumference; FBG, fasting blood glucose; OGT, 2-h oral glucose tolerance; RSBP, resting systolic blood pressure; RDBP, resting diastolic blood pressure; RHR, resting heart rate; LDL-C, fasting LDL-cholesterol; HDL-C, fasting HDL-cholesterol; TRG, fasting triglyceride concentration; TC, total cholesterol; *, statistically significant difference between groups (p< 0.05). Data presented as Mean ± standard deviation, (sample size)